Quick Answer
Coherus Oncology, Inc. reported Total Revenue of $0.00 for the year ending 2018.
- Coherus Oncology, Inc. showed a decrease of -100.0% in Total Revenue from 2017 to 2018.
- This data is from Coherus Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2019.
- XBRL data for this metric is available from 2016 to 2018 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $1.40 million.
- Over the full 3 years of available data (2016 to 2018), Coherus Oncology, Inc.'s Total Revenue has declined by 100.0%.
- Historical annual values: Fiscal year 2018: $0.00 | Fiscal year 2017: $1.56 million | Fiscal year 2016: $190.11 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: